Finch Therapeutics Group, Inc.
FNCH
$13.25
-$0.20-1.49%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.17M | -16.28M | -74.75M | -98.72M | -136.68M |
| Total Depreciation and Amortization | 183.00K | 196.00K | 1.52M | 2.88M | 4.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.34M | 1.46M | 47.15M | 56.81M | 76.89M |
| Change in Net Operating Assets | -6.41M | -7.85M | -5.42M | -3.04M | -354.00K |
| Cash from Operations | -18.06M | -22.49M | -31.51M | -42.07M | -55.90M |
| Capital Expenditure | 14.00K | 14.00K | 0.00 | -65.00K | -393.00K |
| Sale of Property, Plant, and Equipment | 57.00K | 1.33M | 1.33M | 1.29M | 1.27M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 71.00K | 1.34M | 1.33M | 1.23M | 877.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -15.00M | -15.01M | -15.01M |
| Issuance of Common Stock | -- | -- | -- | 60.00K | 104.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 4.00K | -1.16M | -1.16M | -1.16M |
| Cash from Financing | 0.00 | 4.00K | -16.16M | -16.10M | -16.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.98M | -21.14M | -46.33M | -56.95M | -71.09M |
